In this article, we present the case of a man with PsA who experienced not only improvement in his psoriasis and arthritis with the anti-TNF-α agent etanercept but also recurrent hypoglycemia and significant improvement in hemoglobin A1c (HbA1c) despite discontinuation of all conventional therapy for diabetes. The gene discussed is TNF; the disease is psoriasis.